Role of radiotherapy in the treatment of gliomas

References

• Bauman G, Lote K, Larson D et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int. J. Radiat. Oncol. Biol. Phys. 45(4), 923–929 (1999).
   PubMed Web of Science ®Google Scholar
• Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J. Clin. Oncol. 20(8), 2076–2084 (2002).
   PubMed Web of Science ®Google Scholar
• Leibel SA, Sheline GE, Wara WM, Boldrey EB, Nielsen SL. The role of radiation therapy in the treatment of astrocytomas. Cancer 35(6), 1551–1557 (1975).
   PubMed Web of Science ®Google Scholar
• Fazekas JT. Treatment of grades I and II brain astrocytomas. The role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2(7–8), 661–666 (1977).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Daumas-Duport C, Scheithauer BW et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J. Neurosurg. 70(6), 853–861 (1989).
   PubMed Web of Science ®Google Scholar
• Garcia DM, Fulling KH, Marks JE. The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum. Cancer 55(5), 919–927 (1985).
   PubMed Web of Science ®Google Scholar
• Shaw E, Arusell R, Scheithauer B et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J. Clin. Oncol. 20(9), 2267–2276 (2002).
   PubMed Web of Science ®Google Scholar
• Karim AB, Maat B, Hatlevoll R et al. A randomized trial on dose–response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int. J. Radiat. Oncol. Biol. Phys. 36(3), 549–556 (1996).
   PubMed Web of Science ®Google Scholar
• Karim AB, Afra D, Cornu P et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int. J. Radiat. Oncol. Biol. Phys. 52(2), 316–324 (2002).
   PubMed Web of Science ®Google Scholar
• Van den Bent M, de Witte O, Hassel MB et al. Long-term results of trial EORTC 22845/MRC BR4: a randomized trial on the efficacy of radiation therapy (RT) in adult low-grade glioma. Neurooncol. 6(4), 364–365 (2004).
   Google Scholar
• Jeremic B, Milicic B, Grujicic D et al. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a Phase II study. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 465–471 (2003).
   PubMed Web of Science ®Google Scholar
• Grabb PA, Lunsford LD, Albright AL, Kondziolka D, Flickinger JC. Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 38(4), 696–701 (1996).
   PubMed Web of Science ®Google Scholar
• Barcia JA, Barcia-Salorio JL, Ferrer C, Ferrer E, Algas R, Hernandez G. Stereotactic radiosurgery of deeply seated low grade gliomas. Acta Neurochir. 62(Suppl.), 58–61 (1994).
   Google Scholar
• Kihlstrom L, Lindquist C, Lindquist M, Karlsson B. Stereotactic radiosurgery for tectal low-grade gliomas. Acta Neurochir. 62(Suppl.), 55–57 (1994).
   Google Scholar
• Kida Y, Kobayashi T, Mori Y. Gamma knife radiosurgery for low-grade astrocytomas: results of long-term follow up. J. Neurosurg. 93(Suppl. 3), 42–46 (2000).
   Google Scholar
• Ricci PE, Dungan DH. Imaging of low- and intermediate-grade gliomas. Semin. Radiat. Oncol. 11(2), 103–112 (2001).
   Google Scholar
• Pirzkall A, Nelson SJ, McKnight TR et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int. J. Radiat. Oncol. Biol. Phys. 53(5), 1254–1264 (2002).
   PubMedGoogle Scholar
• Eyre HJ, Crowley JJ, Townsend JJ et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J. Neurosurg. 78(6), 909–914 (1993).
   PubMed Web of Science ®Google Scholar
• Brada M, Viviers L, Abson C et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann. Oncol. 14(12), 1715–1721 (2003).
   PubMed Web of Science ®Google Scholar
• Quinn JA, Reardon DA, Friedman AH et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J. Clin. Oncol. 21(4), 646–651 (2003).
   PubMed Web of Science ®Google Scholar
• Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet 3(3), 159–168 (2004).
   Google Scholar
• Klein M, Heimans JJ, Aaronson NK et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343), 1361–1368 (2002).
   PubMed Web of Science ®Google Scholar
• Swennen MH, Bromberg JE, Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J. Neuro-oncol. 66(3), 333–339 (2004).
   PubMed Web of Science ®Google Scholar
• Walker MD, Alexander E Jr, Hunt WE et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg. 49, 333–343 (1978).
   PubMed Web of Science ®Google Scholar
• Curran WJ Jr, Scott CB, Horton J et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl Cancer Inst. 85(9), 704–710 (1993).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Seiferheld W, Scott C et al. Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. Int. J. Radiat. Oncol. Biol. Phys. 57(2 Suppl. 1), S135 (2003).
   Google Scholar
• Shapiro WR, Young DF. Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch. Neurol. 33(7), 494–450 (1976).
   PubMedGoogle Scholar
• Andersen AP. Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol. Oncol. Radiat. Phys. Biol. 17(6), 475–484 (1978).
   PubMed Web of Science ®Google Scholar
• Walker MD, Green SB, Byar DP et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303(23), 1323–1329 (1980).
   PubMed Web of Science ®Google Scholar
• Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 16(6), 1405–1409 (1989).
   PubMed Web of Science ®Google Scholar
• Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 30(9), 907–911 (1980).
   PubMed Web of Science ®Google Scholar
• Garden AS, Maor MH, Yung WK et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother. Oncol. 20(2), 99–110 (1991).
   Google Scholar
• Liang BC, Thornton AF Jr, Sandler HM, Greenberg HS. Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J. Neurosurg. 75(4), 559–563 (1991).
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg. 66(6), 865–874 (1987).
   PubMed Web of Science ®Google Scholar
• Lee SW, Fraass BA, Marsh LH et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int. J. Radiat. Oncol. Biol. Phys. 43(1), 79–88 (1999).
   PubMedGoogle Scholar
• Walker MD, Strike TA, Sheline GE. An analysis of dose–effect relationship in the radiotherapy of malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 5, 1725–1731 (1979).
   PubMed Web of Science ®Google Scholar
• Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br. J. Cancer 64(4), 769–774 (1991).
   PubMed Web of Science ®Google Scholar
• Chan JL, Lee SW, Fraass BA et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J. Clin. Oncol. 20(6), 1635–1642 (2002).
   PubMed Web of Science ®Google Scholar
• Phillips C, Guiney M, Smith J, Hughes P, Narayan K, Quong G. A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother. Oncol. 68(1), 23–26 (2003).
   PubMedGoogle Scholar
• Roa W, Brasher PM, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol. 22(9), 1583–1588 (2004).
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Alexander E III, Shea WM et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J. Clin. Oncol. 10(9), 1379–1385 (1992).
   PubMed Web of Science ®Google Scholar
• Sarkaria JN, Mehta MP, Loeffler JS et al. Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 32(4), 931–941 (1995).
   PubMed Web of Science ®Google Scholar
• Souhami L, Seiferheld W, Brachman D et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93–05 protocol. Int. J. Radiat. Oncol. Biol. Phys. 60(3), 853–860 (2004).
   PubMed Web of Science ®Google Scholar
• Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother. Oncol. 64(3), 259–273 (2002).
   PubMed Web of Science ®Google Scholar
• Selker RG, Shapiro WR, Burger P et al. The Brain Tumor Cooperative Group NIH Trial 87–01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51(2), 343–355 (2002).
   Google Scholar
• Sneed PK, Gutin PH, Larson DA et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int. J. Radiat. Oncol. Biol. Phys. 29(4), 719–727 (1994).
   PubMed Web of Science ®Google Scholar
• Tatter SB, Shaw EG, Rosenblum ML et al. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J. Neurosurg. 99(2), 297–303 (2003).
   PubMed Web of Science ®Google Scholar
• Coughlin C, Scott C, Langer C, Coia L, Curran W, Rubin P. Phase II, two-arm RTOG trial (94–11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int. J. Radiat. Oncol. Biol. Phys. 48(5), 1351–1358 (2000).
   PubMedGoogle Scholar
• Laramore GE, Diener-West M, Griffin TW et al. Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 14(6), 1093–1102 (1988).
   PubMed Web of Science ®Google Scholar
• Fitzek MM, Thornton AF, Rabinov JD et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a Phase II prospective trial. J. Neurosurg. 91(2), 251–260 (1999).
   PubMed Web of Science ®Google Scholar
• Hirose Y, Berger MS, Pieper RO. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Treat. Res. 61(5), 1957–1963 (2001).
   Google Scholar
• Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES. In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8(1), 92–97 (1997).
   PubMed Web of Science ®Google Scholar
• van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ. Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int. J. Radiat. Oncol. Biol. Phys. 47(3), 779–784 (2000).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, Van Den Bent MJ et al. Concomitant and adjuvant temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme. Conclusive results of a randomized Phase III trial by the EORTC Brain and RT Groups and NCIC Clinical Trials Group. J. Clin. Oncol. 22(Suppl.), 14S (2004).
   Google Scholar
• Shaw EG, Stieber V, Tatter S et al. A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM). Int. J. Radiat. Oncol. Biol. Phys. 54(2 Suppl. 1), 206 (2002).
   Google Scholar
• Suzuki M, Nakamatsu K, Kanamori S et al. Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). Jpn J. Clin. Oncol. 33(6), 271–277 (2003).
   Google Scholar
• Shinojima N, Tada K, Shiraishi S et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Treat. Res. 63(20), 6962–6970 (2003).
   Google Scholar
• Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Cell. Biol. 4(1), 121–133 (1993).
   Google Scholar
• Chakravarti A, Seiferheld W, Robbins I et al. Phase I results from RTOG BR-0211, a phase I/II study of an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD 1839 (Iressa), with radiation therapy in glioblastoma multiforme (GBM). Int. J. Radiat. Oncol. Biol. Phys. 57(2 Suppl. 1), S329 (2003).
   Google Scholar
• Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG. Genetic and hypoxic regulation of angiogenesis in gliomas. J. Neurooncol. 70(2), 229–243 (2004).
   PubMed Web of Science ®Google Scholar
• Ohnishi T, Taki T, Hiraga S, Arita N, Morita T. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem. Biophys. Res. Commun. 245(2), 319–324 (1998).
   PubMed Web of Science ®Google Scholar
• Emrich JG, Brady LW, Quang TS et al. Radioiodinated (I-125) monoclonal antibody 425 in the treatment of high grade glioma patients: ten-year synopsis of a novel treatment. Am. J. Clin. Oncol. 25(6), 541–546 (2002).
   PubMed Web of Science ®Google Scholar